Envisagenics

Envisagenics is an AI-driven biotechnology company focused on developing RNA-based therapeutics to treat diseases such as cancer and neurodegenerative disorders. Their flagship technology, SpliceCore®, is a cloud-based platform that leverages machine learning to identify and validate drug targets that modulate RNA splicing events. SpliceCore® has been validated through collaborations with major pharmaceutical companies such as Biogen and Bristol Myers Squibb, and Envisagenics is currently developing its own internal RNA therapeutic programs.

Envisagenics is a minority and woman-led company, with a strong focus on diversity and inclusion. They are committed to developing equitable and accessible healthcare solutions, driven by the belief that a diverse team leads to better science. Their dedication to innovation and a culture of continuous learning has resulted in a robust pipeline of potential therapeutics and numerous awards and recognitions, including SBIR grants from the National Institutes of Health and recognition as the North American Winner of the Innovate.AI Competition.

Envisagenics offers employees a generous benefits package, including flexible time off to recharge, travel and spend time with family. They also cover the cost of transit passes and Citi Bike memberships for local employees and provide parental leave to ease the transition back to work for new parents.

Envisagenics provides comprehensive employee benefits to support a healthy work-life balance and foster a positive work environment. These benefits include medical, dental, and vision insurance for employees and their families. The company encourages and sponsors continuous learning through informal science clubs and supports employees in taking time off to recharge. They also provide commuter benefits by covering the cost of transit passes and Citi Bike memberships for local employees. To support families, Envisagenics offers parental leave and stock options. Finally, employees can participate in a 401(k) plan with a 4% match and no cliff.

Envisagenics is an AI-driven biotechnology company that leverages the therapeutic potential of RNA splicing to develop novel treatments for cancer and other genetic diseases. The company's SpliceCore® platform analyzes vast amounts of RNA sequencing data to identify disease-specific targets and design highly specific therapeutics that modulate RNA splicing events. Envisagenics collaborates with biopharmaceutical companies and academic institutions to accelerate the development of these RNA-based therapies and improve patient outcomes.

Envisagenics fosters a collaborative and diverse work environment that values innovation and improvement in patient care. The company embraces a mission-driven culture, recognizing the importance of family and work-life balance. It emphasizes inclusivity and opportunity for all, creating a supportive environment where diverse perspectives are celebrated and nurtured. This commitment to diversity is reflected in its leadership, with 50% of its executives and employees being women.

Envisagenics is a woman and minority-led company that prioritizes a diverse and inclusive workplace culture, believing that respect and opportunity for all, regardless of race, sex, or creed, leads to great science. Since its inception in 2014, Envisagenics has fostered a culture of inclusion and opportunity, with family-friendly policies and leadership positions for everyone at every level. As a result, 50% of Envisagenics’ executives and employees are women. The company actively recruits, develops, and retains a diverse and multidisciplinary team of collaborators to ensure that all points of view are considered and nurtured.